Probiotics Show Promise In Treating Gastrointestinal Diseases

Main Category: MRSA / Drug Resistance
Also Included In: Infectious Diseases / Bacteria / Viruses;  GastroIntestinal / Gastroenterology;  Nutrition / Diet
Article Date: 08 May 2006 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

4.75 (4 votes)

Healthcare Prof:5 stars

4.75 (4 votes)


Current interest in probiotics is motivated not only by the clinical data showing the efficacy of some probiotic bacteria, but also by the increasing antibiotic resistance of pathogenic bacteria (particularly in hospitals) and the rise of consumers' demand for natural substitutes of drugs.

Among probiotic applications, reduction of diarrhea is probably the best-documented effect confirmed by recent meta-analyses. Research on Helicobacter pylori indicates that probiotics are unable to eradicate the infection, but could be useful in decreasing infection levels and as adjuvants of therapy-associated side effects. Studies performed in inflammatory bowel disease suggest that high doses of probiotics and most likely a combination of different lactobacilli and bifidobacteria are more effective in decreasing inflammatory score and maintaining patients in remission than a single probiotic strain. Probiotic studies evaluating amelioration of symptoms in irritable bowel syndrome would require more sustained patient numbers, but the efficacy seems to be strain-dependent. Not enough probiotic intervention trials have been reported on colon cancer to allow any firm conclusion.

Few randomized, double-blind placebo-controlled human trials are available, and some involved only small numbers of patients. They are difficult to compare because of the differences in probiotic strains employed, doses and formulation. However, the accumulated data is encouraging.

About the S. KARGER AG

With over a century of experience in connecting the world of biomedical science, Karger publishes nearly 80 scientific, peer-reviewed journals and 150 serial and non-serial books and supplement issues annually for a global scientific readership.

S. KARGER AG
Allschwilerstrasse 10,
P.O Box,
CH-4009 Basel,
http://www.karger.com

Article adapted by Medical News Today from original press release.
Visit our mrsa / drug resistance section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Robert Backing. "Probiotics Show Promise In Treating Gastrointestinal Diseases." Medical News Today. MediLexicon, Intl., 8 May. 2006. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/42901.php>

APA
Robert Backing. (2006, May 8). "Probiotics Show Promise In Treating Gastrointestinal Diseases." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/42901.php.

Please note: If no author information is provided, the source is cited instead.


MRSA / Drug Resistance

Most Popular Articles



Follow Our MRSA News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our MRSA / Drug Resistance Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »